This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Suicidality and Substance Abuse in Affective Disorders

Joseph F. Goldberg, MD; Tara M. Singer, MA; and Jessica L. Garno; MA

Published: January 12, 2001

Article Abstract

The relationship between suicidality and substance abuse has long been recognized, althoughstudies have only fairly recently begun to identify factors that may help clarify how alcohol or otherdrug abuse increases the susceptibility to suicidal behavior in vulnerable populations. In particular,alcohol and other psychoactive substance misuse has been linked with mood destabilization and theinduction of manic or depressive episodes in affectively ill individuals, while also demarcatinggroups with heightened tendencies toward impulsivity, aggression, and sensitivity to interpersonalloss. Serotonergic mechanisms have been implicated in each of these clinical settings, along withpossible dysregulation of other neurotransmitter systems. Psychosocial aspects of alcohol or drugabuse relevant to suicide may involve a heightened sensitivity to interpersonal loss, poor copingskills in response to adverse life events, and affective dysregulation induced by circadian andpsychosocial stresses. Consequently, self-destructive behaviors with relatively little premeditationmay arise during periods of increased stress, intoxication, depression, or other psychopathology.Early detection of substance abuse followed by appropriate pharmacologic and/or psychotherapeuticinterventions may greatly help to minimize the formation of complex comorbid psychiatric conditionsand reduce the potential for suicidal acts among high-risk populations.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: Depression (MDD) , Suicide

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...

Read More...